Grant: Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Université Laval
$18,549.00
From skin to joints: common mechanism of damage due to chronic inflammation
FY 2012-13
Summary
We have assembled a unique team of investigators that offers a combination of clinical and research expertise around inflammation and the damage it can cause to tissue such as the skin, joints and blood vessels and the function of the person having to live with those damages. The skin is a natural barrier to the outside world for the body and it is a unique organ capable of inflammation. It is easy to access for research and can be triggered to produce inflammatory fluids that can be collected and studied in the laboratory. The study of wound healing can help us understand joint tissue healing and response to inflammation as a whole by the identification of biomarkers associated with damage. Not surprisingly, chronic inflammatory diseases that affect the skin often affect the joints as well. The main objective of our research program is to identify biological and clinical markers associated with and predictive of skin, joint and blood vessel damage due to chronic inflammation. We will study four inflammatory diseases that range from a predominance of skin manifestations to those with a predominance of joints manifestations. They are psoriasis (PsO) and psoriatic arthritis (PsA), systemic sclerosis (SSc), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA). Specifically, we will work on three aims: 1) we will study clinical predictors of damage in human disease and develop instruments to predict this damage that will include the biomarkers that we will have identified; 2) we will study normal and abnormal wound healing to understand how chronic inflammation leads to damage; and 3) we will search for inflammation-associated molecules that are common to the inflammation of these diseases. We are even envisioning that how the skin respond to inflammation could be measured, standardized and used as a test to predict how other organs in the body such as the joints or blood vessels will respond as well.
Department
Program
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
276905
Name
Fortin Paul R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Projecttitle
From skin to joints: common mechanism of damage due to chronic inflammation
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$18,549
Cihrequipment2
$0
Programname2
Team Grant: Health Challenges in Chronic Inflammation Initiative (LOI)
Keyworddelim
Biomarkers; Chronic Inflammation; Damage; Inflammation-Associated Molecules; Microparticles; Psoriasis; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Systemic Sclerosis; Wound Healing
Abstract
We have assembled a unique team of investigators that offers a combination of clinical and research expertise around inflammation and the damage it can cause to tissue such as the skin, joints and blood vessels and the function of the person having to live with those damages. The skin is a natural barrier to the outside world for the body and it is a unique organ capable of inflammation. It is easy to access for research and can be triggered to produce inflammatory fluids that can be collected and studied in the laboratory. The study of wound healing can help us understand joint tissue healing and response to inflammation as a whole by the identification of biomarkers associated with damage. Not surprisingly, chronic inflammatory diseases that affect the skin often affect the joints as well. The main objective of our research program is to identify biological and clinical markers associated with and predictive of skin, joint and blood vessel damage due to chronic inflammation. We will study four inflammatory diseases that range from a predominance of skin manifestations to those with a predominance of joints manifestations. They are psoriasis (PsO) and psoriatic arthritis (PsA), systemic sclerosis (SSc), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA). Specifically, we will work on three aims: 1) we will study clinical predictors of damage in human disease and develop instruments to predict this damage that will include the biomarkers that we will have identified; 2) we will study normal and abnormal wound healing to understand how chronic inflammation leads to damage; and 3) we will search for inflammation-associated molecules that are common to the inflammation of these diseases. We are even envisioning that how the skin respond to inflammation could be measured, standardized and used as a test to predict how other organs in the body such as the joints or blood vessels will respond as well.
Competitiondate
201211
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fortin, Paul R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $18,549~ $0~